Ares Capital Corp.

  • Market Cap: Mid Cap
  • Industry: Capital Markets
  • ISIN: US04010L1035
USD
20.92
0.28 (1.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Ares Capital Corp. stock-summary
stock-summary
Ares Capital Corp.
Capital Markets
Ares Capital Corporation is a specialty finance company. The Company operates as a closed-end, non-diversified management investment company. The Company's investment objective is to generate both current income and capital appreciation through debt and equity investments. It invests primarily in the United States middle-market companies. It may from time to time invest in larger or smaller (in particular, for investments in early-stage and/or venture capital-backed) companies. It invests primarily in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and mezzanine debt, generally in a first lien position), second lien senior secured loans, and mezzanine debt, which in some cases includes an equity component. It invests in various industries, such as automotive services, business services, consumer products, and containers and packaging. Ares Capital Management LLC serves as its investment advisor.
Company Coordinates stock-summary
Company Details
245 Park Ave Fl 44 , NEW YORK NY : 10167-4400
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 25 Schemes (3.3%)

Foreign Institutions

Held by 99 Foreign Institutions (6.1%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Michael Arougheti
Co-Chairman of the Board, Executive Vice President
Mr. Bennett Rosenthal
Co-Chairman of the Board
Mr. Robert deVeer
Chief Executive Officer, Director
Mr. Eric Siegel
Lead Independent Director
Mr. Robert Rosen
Director
Mr. H. Stephen Bartlett
Independent Director
Ms. Ann Bates
Independent Director
Mr. Daniel Kelly
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
822 Million
(Quarterly Results - Jun 2025)
Net Profit:
361 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 15,864 Million (Mid Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

6.75%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

9.64%

stock-summary
Price to Book

1.13